RALA and neoplasm: To test this hypothesis, we implanted folate receptor negative 4T1 murine breast cancer cells into BALB/c mice and injected the tumor-bearing mice intravenously with the same fluorescent folate-S0456 or Ral-S0456 conjugate employed above (Figure S2).